Limit by hypherphosphatemia ofthe usefulness of vitamin D metabolites (1α-hydroxycholecalciferol and 25-hydroxycholecalciferol) in the treatment of renal osteodystrophy

Brickman, 1974, 1,25-dihydroxycholecalciferol — Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy, Arch. Intern. Med., 134, 883, 10.1001/archinte.1974.00320230093020 Brownjohn, 1977, 1-alpha-hydroxycholecalciferol for renal osteodystrophy, Brit. Med. J., 2, 721, 10.1136/bmj.2.6089.721 Canterbury, 1979, In vivo suppression of parathyroid hormone (PTH) secretion by 24,25-dihydroxycholecalciferol [24,25(OH)2D3] in hyperparathyroid dogs, 297 Davie, 1976, 1-alpha-hydroxycholecalciferol in chronic renal failure. Studies of the effect of oral doses, Ann. Intern. Med., 84, 281, 10.7326/0003-4819-84-3-281 Ellis, 1977, Histopathology of renal osteodystrophy with particular reference to the effects of 1-α-hydroxyvitamin D3 in patients treated by long-term haemodialysis, Clin. Endocrinol., 7 S, 31, 10.1111/j.1365-2265.1977.tb03359.x Fournier, 1971, Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. II. Factors affecting serum immunoreactive parathyroid hormone, J. Clin. Invest., 50, 599, 10.1172/JCI106530 Fournier, 1975, Effects of phosphate binders on bone formation and resorption in patients on chronic hemodialysis with and without kidneys, 577 Fournier, 1979, Comparison of 1-alpha-hydroxycholecalciferol and 25-hydroxycholecalcife rol in the treatment of renal osteodystrophy : Greater effect of 25-hydroxycholecalciferol on bone mineralization, Kidney Internatl., 15, 196, 10.1038/ki.1979.25 Fournier, 1971, Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. I. Association of bone disease with potentially etiologic factors, J. Clin. Invest., 50, 592, 10.1172/JCI106529 Guéris, 1975, Heterogeneite de la parathormone plasmatique chez I'homme, Pathol. Biol., 23, 821 Johnson, 1974, Prevention and reversal of progressive secondary hyperparathyroidism in patients maintained by hemodialysis, Am. J. Med., 56, 827, 10.1016/0002-9343(74)90811-0 Kanis, 1978, Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?, Brit. Med. J., 1, 1382, 10.1136/bmj.1.6124.1382 Malluche, 1976, Changes of bone histology during maintenance hemodialysis at various levels of dialysate calcium concentration, Clin. Nephrol., 6, 440 Massry, 1976, Divalent ion metabolism and renal osteodystrophy, 304 Meunier, 1977, Histomorphometry of osteoid tissue — The hype rosteoidoses, 249 Meyrier, 1973, The influence of a high calcium carbonate on bone in patients undergoing hemodialysis, Kidney Internatl., 4, 146, 10.1038/ki.1973.93 Pierides, 1976, Variable response to long-term 1-α-hydroxycholecalciferol in haemodialysis osteodystrophy, Lancet, 1, 1092, 10.1016/S0140-6736(76)90061-1 Pierides, 1976, 1-α-hydroxycholecalciferol in hemodialysis renal osteodystrophy Adverse effects of anticonvulsant therapy, Clin. Nephrol., 5, 189 Preece, 1974, A competitive protein binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocholecalciferol, Clin. Chim. Acta, 54, 235, 10.1016/0009-8981(74)90241-1 Rasmussen, 1974 Recker, 1978, The efficacy of calcifediol in renal osteodystrophy, Arch. Intern. Med., 138, 857, 10.1001/archinte.138.Suppl_5.857 Ward, 1978, Osteomalacic dialysis osteodystrophy : Evidence for a water-bone aetiological agent, probably aluminium, Lancet, 1, 841, 10.1016/S0140-6736(78)90191-5